Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1194815

CCCCCCCCCCCCCCCCCC(=O)N[N+](C)(C)CCC.Cl.Cl

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 known ✓ P07900 1/20 0.52
▸ FAAH O00519 8/20 0.50
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ CES2 O00748 3/20 0.43
▸ CES1 P23141 3/20 0.43
▸ TRPV1 Q8NER1 3/20 0.42
▸ DNM1 Q05193 2/20 0.42
▸ CNR1 P21554 1/20 0.42
▸ CNR2 P34972 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9386494 1.00 HSP90AA1 (0.52) HSP90AA1FAAHMEN1KMT2AMAPK1
Hydrochloric Acid SCHEMBL1194814 0.98 HSP90AA1 (0.50) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL9409008 0.98 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL74417 0.98 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL90355 0.98 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL23352 0.98 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL680383 0.98 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL10420923 0.98 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL15994305 0.98 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1
SCHEMBL1482878 0.98 HSP90AA1 (0.53) HSP90AA1FAAHMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2325278-B1 Polycationic viscoelastic compositions STEPAN CO (US) 2015-09-09 — — EP disclosed
US-8222455-B2 Polycationic viscoelastic compositions STEPAN COMPANY (US) 2012-07-17 — — US disclosed
EP-1945734-B1 POLYCATIONIC VISCOELASTIC COMPOSITIONS STEPAN CO (US) 2011-08-17 — — EP disclosed
US-20110190530-A1 Polycationic Viscoelastic Compositions KNOX PAUL 2011-08-04 — — US disclosed
EP-2325278-A1 Polycationic viscoelastic compositions STEPAN COMPANY (US) 2011-05-25 — — EP disclosed
US-7947633-B2 Polycationic viscoelastic compositions STEPAN COMPANY (US) 2011-05-24 — — US disclosed
US-7884057-B2 Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. STEPAN COMPANY (US) 2011-02-08 — — US disclosed
US-7879769-B2 Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. STEPAN COMPANY (US) 2011-02-01 — — US disclosed
US-20100311622-A1 Polycationic Viscoelastic Compositions KNOX PAUL 2010-12-09 — — US disclosed
US-7772165-B2 Polycationic viscoelastic compositions STEPHAN COMPANY (US) 2010-08-10 — — US disclosed
EP-1945734-A4 POLYCATIONIC VISCOELASTIC COMPOSITIONS STEPAN CO (US) 2008-12-03 — — EP disclosed
US-20080255009-A1 Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. STEPAN COMPANY 2008-10-16 — — US disclosed
US-20080248976-A1 POLYCATIONIC VISCOELASTIC COMPOSITIONS STEPAN COMPANY 2008-10-09 — — US disclosed
US-20080248977-A1 Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. STEPAN COMPANY 2008-10-09 — — US disclosed
EP-1945734-A2 POLYCATIONIC VISCOELASTIC COMPOSITIONS STEPAN COMPANY (US) 2008-07-23 — — EP disclosed
WO-2007056392-A9 POLYCATIONIC VISCOELASTIC COMPOSITIONS STEPAN CO (US) 2007-07-05 — — WO disclosed
WO-2007056284-A2 POLYCATIONIC VISCOELASTIC COMPOSITIONS STEPAN COMPANY (US) 2007-05-18 — — WO disclosed
WO-2007056393-A2 POLYCATIONIC VISCOELASTIC COMPOSITIONS STEPAN COMPANY (US) 2007-05-18 — — WO disclosed
WO-2007056392-A2 POLYCATIONIC VISCOELASTIC COMPOSITIONS STEPAN COMPANY (US) 2007-05-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190530-A1 Polycationic Viscoelastic Compositions AQP1, PBRM1, PARG HSP90AA1 3394/4885FAAH 3634/4885MEN1 2036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback